Philips, Paris, France.
Ecole Supérieure d'Electronique de l'Ouest, Angers, France.
J Clin Sleep Med. 2020 Dec 15;16(12):2037-2046. doi: 10.5664/jcsm.8752.
To assess, in a large cohort of patients with obstructive sleep apnea, the factors that are independently associated with positional obstructive sleep apnea (POSA) and exclusive POSA (e-POSA) and determine their prevalence. The secondary objective was to evaluate the outcome of positive airway pressure (PAP) therapy for patients with POSA and e-POSA.
This retrospective study included 6,437 patients with typical mild-to-severe OSA from the Pays de la Loire sleep cohort. Patients with POSA and e-POSA were compared to those with non-POSA for clinical and polysomnographic characteristics. In a subgroup of patients (n = 3,000) included in a PAP follow-up analysis, we determined whether POSA and e-POSA phenotypes were associated with treatment outcomes at 6 months.
POSA and e-POSA had a prevalence of 53.5% and 20.1%, respectively, and were independently associated with time in supine position, male sex, younger age, lower apnea-hypopnea index and lower body mass index. After adjustment for confounding factors, patients with POSA and e-POSA had a significantly lower likelihood of treatment adherence (PAP daily use ≥ 4 h) at 6 months and were at higher risk of PAP treatment withdrawal compared to those with non-POSA.
The prevalence and independent predictors of POSA and e-POSA were determined in this large clinical population. Patients with POSA and e-POSA have lower PAP therapy adherence, and this choice of treatment may not be optimal. Thus, there is a need to offer these patients an alternative therapy.
在大量阻塞性睡眠呼吸暂停患者中,评估与体位性阻塞性睡眠呼吸暂停(POSA)和单纯体位性睡眠呼吸暂停(e-POSA)独立相关的因素,并确定其患病率。次要目的是评估 POSA 和 e-POSA 患者持续气道正压通气(PAP)治疗的效果。
这项回顾性研究纳入了来自卢瓦尔河地区睡眠队列的 6437 名典型的轻至重度 OSA 患者。将 POSA 和 e-POSA 患者与非 POSA 患者进行比较,以评估其临床和多导睡眠图特征。在纳入 PAP 随访分析的患者亚组(n=3000)中,我们确定 POSA 和 e-POSA 表型是否与 6 个月时的治疗效果相关。
POSA 和 e-POSA 的患病率分别为 53.5%和 20.1%,与仰卧位时间、男性、年龄较小、呼吸暂停低通气指数较低和体重指数较低独立相关。在校正混杂因素后,POSA 和 e-POSA 患者在 6 个月时的治疗依从性(PAP 每日使用≥4 小时)显著降低,与非 POSA 患者相比,更有可能停止 PAP 治疗。
在这项大型临床人群中确定了 POSA 和 e-POSA 的患病率和独立预测因素。POSA 和 e-POSA 患者的 PAP 治疗依从性较低,这种治疗选择可能并不理想。因此,需要为这些患者提供替代治疗。